The need for therapeutic tools in the fight against SARS-CoV-2, the virus causing the COVID-19 pandemic, has fostered the interest in vimentin as a potential therapeutic target in viral infections, a subject addressed in several recent reviews and hypotheses12,24,25. The gene discussed is VIM; the disease is viral infectious disease.